Bioxodes

Stroke and intracerebral haemorrhage

Bioxodes is focused on clinical research in spontaneous intracerebral haemorrhage, with interest in the acute management of brain bleeding and related neurological injury.

  • Haemorrhagic stroke
  • Acute neurological care
  • Brain haemorrhage

The sponsor’s clinical activity is centered on treatment-related evaluation in adult patients affected by intracerebral haemorrhage.

Haemostasis and contact phase inhibition

Its research interest includes coagulation-related mechanisms, especially pathways linked to contact phase inhibition in the setting of bleeding disorders and cerebrovascular injury.

  • Coagulation pathways
  • Contact system
  • Bleeding control

This places emphasis on therapeutic areas where modulation of haemostatic processes may be relevant to patients with intracranial bleeding.

Neurology and cerebrovascular disease

The sponsor’s research landscape extends into neurological conditions involving vascular injury, with attention to clinical outcomes in acute brain events and cerebral circulation disorders.

  • Cerebrovascular disease
  • Acute brain injury
  • Neurological complications

Clinical interest is directed toward patient populations experiencing sudden haemorrhagic events within the central nervous system.

Adult acute care

Bioxodes is involved in research for adult patients requiring urgent evaluation in the context of emergency neurological care and acute hospital management.

  • Adult patients
  • Emergency care
  • Hospital-based treatment

The clinical focus is on conditions where rapid medical assessment is central to managing intracerebral haemorrhage.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effects of Ixodes ricinus Contact Phase Inhibitor in Adults with Spontaneous Brain Bleeding

    Not recruiting

    1 1
    Belgium